Context Therapeutics gets Nasdaq notice for failing $1 minimum bid price rule - CNTX News | RalliesContext Therapeutics gets Nasdaq notice for failing $1 minimum bid price rule
C
CNTX• Nasdaq notice for minimum bid price deficiency
- Context Therapeutics received a Nasdaq notice for failing to meet the $1 minimum bid price requirement for 30 consecutive business days.
- Shares remain listed for now, with an initial compliance window running through Jan. 25, 2027.
- Compliance requires a closing bid price of at least $1 for 10 consecutive business days, subject to Nasdaq discretion.
- Failure to regain compliance could trigger delisting proceedings, with a possible additional 180-day cure period if eligibility conditions are met.
•
